Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J et al (2011) Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 364(26):2507–2516

Article  CAS  PubMed  PubMed Central  Google Scholar 

Long GV, Menzies AM, Nagrial AM, Haydu LE, Hamilton AL, Mann GJ et al (2011) Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma. J Clin oncology: official J Am Soc Clin Oncol 29(10):1239–1246

Article  Google Scholar 

Robert C, Karaszewska B, Schachter J, Rutkowski P, Mackiewicz A, Stroiakovski D et al (2015) Improved overall survival in melanoma with combined dabrafenib and trametinib. N Engl J Med 372(1):30–39

Article  PubMed  Google Scholar 

Larkin J, Ascierto PA, Dreno B, Atkinson V, Liszkay G, Maio M et al (2014) Combined vemurafenib and cobimetinib in BRAF-mutated melanoma. N Engl J Med 371(20):1867–1876

Article  PubMed  Google Scholar 

Dummer R, Ascierto PA, Gogas HJ, Arance A, Mandala M, Liszkay G et al (2018) Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol 19(10):1315–1327

Article  CAS  PubMed  Google Scholar 

Kacinski BM (1995) CSF-1 and its receptor in ovarian, endometrial and breast cancer. Ann Med 27(1):79–85

Article  CAS  PubMed  Google Scholar 

Sasmono RT, Oceandy D, Pollard JW, Tong W, Pavli P, Wainwright BJ et al (2003) A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. Blood 101(3):1155–1163

Article  CAS  PubMed  Google Scholar 

Bourette RP, Rohrschneider LR (2000) Early events in M-CSF receptor signaling. Growth Factors 17(3):155–166

Article  CAS  PubMed  Google Scholar 

Pixley FJ, Stanley ER (2004) CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol 14(11):628–638

Article  CAS  PubMed  Google Scholar 

Lin H, Lee E, Hestir K, Leo C, Huang M, Bosch E et al (2008) Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 320(5877):807–811

Article  CAS  PubMed  Google Scholar 

Nowicki A, Szenajch J, Ostrowska G, Wojtowicz A, Wojtowicz K, Kruszewski AA et al (1996) Impaired tumor growth in colony-stimulating factor 1 (CSF-1)-deficient, macrophage-deficient op/op mouse: evidence for a role of CSF-1-dependent macrophages in formation of tumor stroma. Int J Cancer 65(1):112–119

Article  CAS  PubMed  Google Scholar 

Lewis CE, Pollard JW (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res 66(2):605–612

Article  CAS  PubMed  Google Scholar 

Bingle L, Brown NJ, Lewis CE (2002) The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 196(3):254–265

Article  CAS  PubMed  Google Scholar 

Lin EY, Nguyen AV, Russell RG, Pollard JW (2001) Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193(6):727–740

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mok S, Tsoi J, Koya RC, Hu-Lieskovan S, West BL, Bollag G et al (2015) Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition. BMC Cancer 15:356

Article  PubMed  PubMed Central  Google Scholar 

Wang T, Xiao M, Ge Y, Krepler C, Belser E, Lopez-Coral A et al (2015) BRAF Inhibition stimulates Melanoma-Associated Macrophages to drive Tumor Growth. Clin cancer research: official J Am Association Cancer Res 21(7):1652–1664

Article  CAS  Google Scholar 

Hu-Lieskovan S, Mok S, Homet Moreno B, Tsoi J, Robert L, Goedert L et al (2015) Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanoma. Sci Transl Med 7(279):279ra41

Article  PubMed  PubMed Central  Google Scholar 

Dubreuil P, Torrès H, Courcoul MA, Birg F, Mannoni P (1988) c-fms expression is a molecular marker of human acute myeloid leukemias. Blood 72(3):1081–1085

Article  CAS  PubMed  Google Scholar 

Kacinski BM, Scata KA, Carter D, Yee LD, Sapi E, King BL et al (1991) FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinomas in vivo and in vitro. Oncogene 6(6):941–952

CAS  PubMed  Google Scholar 

Tang R, Beuvon F, Ojeda M, Mosseri V, Pouillart P, Scholl S (1992) M-CSF (monocyte colony stimulating factor) and M-CSF receptor expression by breast tumour cells: M-CSF mediated recruitment of tumour infiltrating monocytes? J Cell Biochem 50(4):350–356

Article  CAS  PubMed  Google Scholar 

Kacinski BM (1997) CSF-1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract. Mol Reprod Dev 46(1):71–74

Article  CAS  PubMed  Google Scholar 

Mroczko B, Groblewska M, Wereszczyńska-Siemiatkowska U, Okulczyk B, Kedra B, Łaszewicz W et al (2007) Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis. Clin Chim Acta 380(1–2):208–212

Article  CAS  PubMed  Google Scholar 

Zhu XD, Zhang JB, Zhuang PY, Zhu HG, Zhang W, Xiong YQ et al (2008) High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J Clin Oncol 26(16):2707–2716

Article  PubMed  Google Scholar 

Scholl SM, Pallud C, Beuvon F, Hacene K, Stanley ER, Rohrschneider L et al (1994) Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. J Natl Cancer Inst 86(2):120–126

Article  CAS  PubMed  Google Scholar 

Pollard JW (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4(1):71–78

Article  CAS  PubMed  Google Scholar